Gordon Beattie

University College London - Cancer Immunology Unit

Gower Street

London, WC1E 6BT

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

198

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Pharmacologic Inhibition of Nonsense-Mediated Decay Induces Anti-Tumour Immunogenicity in Ex Vivo Patient Tumours

Number of pages: 65 Posted: 16 Feb 2024
University College London - UCL Cancer Institute, University College London - UCL Cancer Institute, University College London - UCL Cancer Institute, University College London - UCL Cancer Institute, University College London - UCL Cancer Institute, University College London - UCL Cancer Institute, Weizmann Institute of Science, Weizmann Institute of Science, University College London - UCL Cancer Institute, University College London - UCL Cancer Institute, Genesis Therapeutics, Inc., University College London - Cancer Immunology Unit, University College London - UCL Cancer Institute, University College London - UCL Cancer Institute, University College London - UCL Cancer Institute, University College London - UCL Cancer Institute, University College London - Research Department of Hematology, University College London - UCL Cancer Institute, University College London - UCL Cancer Institute, The Francis Crick Institute, The Hebrew University of Jerusalem, University College London - UCL Cancer Institute, Independent, The Francis Crick Institute, Genesis Therapeutics, Inc., University College London - Cancer Immunology Unit, University College London - UCL Cancer Institute, Weizmann Institute of Science, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, University College London - UCL Cancer Institute and Independent
Downloads 143 (440,440)

Abstract:

Loading...

Nonsense-mediated decay, SMG1, cancer, anti-tumour immunogenicity, neoantigens, frameshift insertions/deletions, patient-derived fragments.

2.

Determinants of Anti-PD1 Response and Resistance in Clear Cell Renal Cell Carcinoma

Number of pages: 64 Posted: 26 Mar 2021
The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Retroviral Immunology, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Cancer Dynamics Laboratory, University College London - Cancer Immunology Unit, The Francis Crick Institute, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Francis Crick Institute - Cancer Dynamics Laboratory, Francis Crick Institute - Cancer Dynamics Laboratory, Royal Marsden NHS Foundation Trust - Renal and Skin Units, Francis Crick Institute - Retroviral Immunology, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Biocruces Bizkaia Health Research Institute - Department of Pathology, Guy's and St Thomas' NHS Foundation Trust - Department of Cellular Pathology, Guy's and St Thomas' NHS Foundation Trust - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Cancer Institute - Cancer Research UK Lung Cancer Centre of Excellence, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, Royal Marsden NHS Foundation Trust - Renal and Skin Units, Royal Marsden NHS Foundation Trust - Renal and Skin Units, University College London - Cancer Immunology Unit, Peter MacCallum Cancer Centre - Division of Research, University College London Hospital - Department of Cellular Pathology, University College London - Cancer Research UK Lung Cancer Centre of Excellence, Independent, The Francis Crick Institute, University College London - Division of Infection and Immunity, Royal Marsden NHS Foundation Trust - Renal and Skin Units, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory and Independent
Downloads 55 (813,308)
Citation 1

Abstract:

Loading...

clear cell renal cell carcinoma, nivolumab, immunotherapy, cytotoxicity, TCR clonal maintenance, TCR clonal replacement, human endogenous retrovirus, longitudinal sampling, multiregion sampling, autopsy